Increased plasma oxidizability and decreased erythrocyte and plasma antioxidative capacity in patients with NIDDM

Israel Medical Association Journal

Volumn 1, Issue 4, 1999, Pages 228-231

  Zaltzberg, Haya ^a   Kanter, Yoram ^a   Aviram, Michael ^a   Levy, Yishai ^a  

^a Lipid Research Unit   (Israel)

Author keywords

Antioxidants; Glutathione redox cycle; Lipid peroxidation; NIDDM; Oxidation

Indexed keywords

ANTIOXIDANT; GLUTATHIONE; LIPID PEROXIDE;

ADULT; ARTERIOSCLEROSIS; ARTICLE; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; ERYTHROCYTE; FEMALE; HUMAN; ISRAEL; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLASMA;

ADULT; ANTIOXIDANTS; ARTERIOSCLEROSIS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ERYTHROCYTES; FEMALE; GLUTATHIONE; HUMANS; ISRAEL; LIPID PEROXIDES; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLASMA;

EID: 0033289624     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham Study, Circulation 1979;59:8-13.
2. Assmann G, Schulte H. The Prospective Cardiovascular Munster (PROCAM) Study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 1988;116:1713-24.
3. Chisolm GM, Irwin KC, Penn MS. Lipoprotein-induced oxidation and lipoprotein-induced cell injury in diabetes. Diabetes 1992;41(Suppl 2):61-5.
4. Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 1993;71:26B-31B.